CulverP. J.WilcoxC. S.JonesC. M.RoseR. S.: Intermediary metabolism of certain polyoxyethylene derivatives in man. I. Recovery of the polyoxyethylene moiety from urine and faeces following ingestion of polyethylene (20) sorbitan monooleate and of polyoxyethylene (40) monostearate. J. Pharmacol. exp. Ther.103 (1951), 377.
MeyerG.StürmerE.: Über Polyaethylenglycole. Studien zur Pharmakologie und Toxikologie mehrwertiger Alkohole. Arch. int. Pharmacodyn.90 (1952), 193.
4.
SchafferC. B.CritchfieldF. H.: The absorption and excretion of the solid polyethylene glycols (‘Carbowax’ compounds). J. Amer. pharm. Ass. sci. Ed.36 (1947), 152.
5.
SchafferC. B.CritchfieldF.H.NairJ. H.: The absorption and excretion of a liquid polyethylene glycol. J. Amer. pharm. Ass. sci. Ed.39 (1950), 340.
6.
ShidemanF. E.ProcitaL.: Some pharmacological actions of polypropylene glycols of average molecular weight 400, 750, 1,200 and 2,000. J. Pharmacol. exp. Ther.103 (1951), 293.
7.
SmythH. F.CarpenterC. P.ShafferC. B.: The subacute toxicity and irritation of polyethylene glycols of approximate molecular weights of 200, 300 and 400. J. Amer. pharm. Ass. sci. Ed.34 (1945), 172.
8.
SmythH. F.CarpenterC. P.ShafferC. B.: The toxicity of high molecular weight polyethylene glycols; chronic oral and parenteral administration. J. Amer. pharm. Ass. sci. Ed.36 (1947), 157.
9.
SmythH. F.CarpenterC. P.ShafferC.B.Weil, C. S.: The toxicology of the polyethylene glycols. J. Amer. pharm. Ass. sci. Ed.39 (1950), 349.
10.
SteigmannF.GoldbergE. M.SchoolmanH. M.: The effect of emulsifying agents (Tween 60 and Span 60) on the gastrointestinal tract. Amer. J. dig. Dis.20 (1953), 380.
11.
UllmanE.: Über die physiologische Verträglichkeit der als Lösungsvermittler und Emulgatoren verwendeten oberflächenaktiven Substanzen unter besonderer Berücksichtigung der Polyäthylenoxydderivate. Mitt. dtsch. pharm. Ges.27 (1957), 1.
